NU50CK000651
Cooperative Agreement
Overview
Grant Description
Oregon Emerging Infections Program - Emerging Infections Program CDC-RFA-CK24-2401 Oregon Health Authority Public Health Division. This submission is Oregon's response to CDC's Emerging Infections Programs announcement (Funding Opportunity Number CDC-RFA-CK24-2401). In this application, the Public Health Division of the Oregon Health Authority requests continued funding for its Emerging Infections Program (EIP), which has been operating since 1995.
The EIP network assists with local, state, and national efforts to prevent, control and monitor the public-health impact of infectious diseases, through (1) active infectious disease surveillance; (2), applied public-health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention and intervention projects; and (4) rapid and flexible response to public-health emergencies and newly emerging issues for infectious diseases.
Oregon requests funding for the following specific activities: - Infrastructure and data modernization - Surveillance and reporting in response to an emerging infectious disease threat - Population-based surveillance for hospitalized cases of influenza (FluSurv-NET) - Population-based surveillance for hospitalized cases of respiratory syncytial virus infection (RSV-NET) - Population-based surveillance for hospitalized cases of COVID-19 (COVID-NET) - Active Bacterial Core Surveillance, including surveillance for legionellosis and pertussis - Foodborne Diseases Active Surveillance Network (FoodNet) - Healthcare-Associated Infections—Community Interface, including o Active surveillance for Clostridium difficile infection o Multi-site Gram-negative Surveillance Initiative (MuGSI) o The Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey o Active surveillance for candidemia o Active surveillance for non-tuberculous mycobacterial (NTM) infection o Special projects, including Epidemiology of Carbapenem-Resistant Acinetobacter (CRA) Infections Analysis and validation of race and ethnicity data reported to the National Healthcare Safety Network (NHSN) Data modernization: Electronic Case Report (ECR) Integration - Human Papillomavirus Vaccine Impact Monitoring Project (HPV-IMPACT) - MPOX Vaccine Effectiveness Evaluation. Funds will be used to hire epidemiology and laboratory staff; to develop and maintain robust surveillance information systems; to purchase necessary laboratory equipment and supplies; for licenses, memberships, and travel to meetings; to contract with collaborating entities; and to conduct epidemiologic research.
The EIP network assists with local, state, and national efforts to prevent, control and monitor the public-health impact of infectious diseases, through (1) active infectious disease surveillance; (2), applied public-health epidemiologic and laboratory activities; (3) implementation and evaluation of pilot prevention and intervention projects; and (4) rapid and flexible response to public-health emergencies and newly emerging issues for infectious diseases.
Oregon requests funding for the following specific activities: - Infrastructure and data modernization - Surveillance and reporting in response to an emerging infectious disease threat - Population-based surveillance for hospitalized cases of influenza (FluSurv-NET) - Population-based surveillance for hospitalized cases of respiratory syncytial virus infection (RSV-NET) - Population-based surveillance for hospitalized cases of COVID-19 (COVID-NET) - Active Bacterial Core Surveillance, including surveillance for legionellosis and pertussis - Foodborne Diseases Active Surveillance Network (FoodNet) - Healthcare-Associated Infections—Community Interface, including o Active surveillance for Clostridium difficile infection o Multi-site Gram-negative Surveillance Initiative (MuGSI) o The Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey o Active surveillance for candidemia o Active surveillance for non-tuberculous mycobacterial (NTM) infection o Special projects, including Epidemiology of Carbapenem-Resistant Acinetobacter (CRA) Infections Analysis and validation of race and ethnicity data reported to the National Healthcare Safety Network (NHSN) Data modernization: Electronic Case Report (ECR) Integration - Human Papillomavirus Vaccine Impact Monitoring Project (HPV-IMPACT) - MPOX Vaccine Effectiveness Evaluation. Funds will be used to hire epidemiology and laboratory staff; to develop and maintain robust surveillance information systems; to purchase necessary laboratory equipment and supplies; for licenses, memberships, and travel to meetings; to contract with collaborating entities; and to conduct epidemiologic research.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Oregon
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 590% from $1,548,250 to $10,686,427.
Oregon Department Of Human Services was awarded
Oregon Emerging Infections Program - CDC-RFA-CK24-2401
Cooperative Agreement NU50CK000651
worth $10,686,427
from National Center for Emerging and Zoonotic Infectious Diseases in January 2024 with work to be completed primarily in Oregon United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.317 Emerging Infections Programs.
The Cooperative Agreement was awarded through grant opportunity Emerging Infections Program.
Status
(Ongoing)
Last Modified 3/20/24
Period of Performance
1/1/24
Start Date
12/31/28
End Date
Funding Split
$10.7M
Federal Obligation
$0.0
Non-Federal Obligation
$10.7M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU50CK000651
Additional Detail
Award ID FAIN
NU50CK000651
SAI Number
NU50CK000651-4203726878
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC OFFICE OF FINANCIAL RESOURCES
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
HFJRBHKCBPR5
Awardee CAGE
1GVR0
Performance District
OR-90
Senators
Jeff Merkley
Ron Wyden
Ron Wyden
Modified: 3/20/24